NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% gel

Ország: Egyesült Államok

Nyelv: angol

Forrás: NLM (National Library of Medicine)

Vedd Meg Most

Letöltés Termékjellemzők (SPC)
02-05-2019

Aktív összetevők:

NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4), TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R), SPIRONOLACTONE (UNII: 27O7W4T232) (SPIRONOLACTONE - UNII:27O7W4T232)

Beszerezhető a:

Sincerus Florida LLC

Az alkalmazás módja:

TOPICAL

Recept típusa:

PRESCRIPTION DRUG

Engedélyezési státusz:

unapproved drug other

Termékjellemzők

                                NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%- NIACINAMIDE 2% /
SPIRONOLACTONE 5% / TRETINOIN 0.05% GEL
SINCERUS FLORIDA LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%
DIRECTIONS FOR USE.
SINCERUS FLORIDA, LLC ADVERSE REACTIONS.
ACTIVE, INACTIVE
NDC 72934-1153
NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%
GEL 30 GM.
NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%
niacinamide 2% / spironolactone 5% / tretinoin 0.05% gel
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-1153
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
Sincerus Florida LLC
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4)
NIACINAMIDE
2 g in 10 0 g
TRETINO IN (UNII: 56 8 8 UTC0 1R) (TRETINOIN - UNII:56 8 8 UTC0 1R)
TRETINOIN
0 .0 5 g in 10 0 g
SPIRO NO LACTO NE (UNII: 27O7W4T232) (SPIRONOLACTONE -
UNII:27O7W4T232)
SPIRONOLACTONE
5 g in 10 0 g
PRODUCT CHARACTERISTICS
COLOR
ye llo w
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END DATE
1
NDC:729 34-1153-
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/0 3/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/0 3/20 19
LABELER -
Sincerus Florida LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-1153)
Revised: 5/2019
                                
                                Olvassa el a teljes dokumentumot
                                
                            

A termékkel kapcsolatos riasztások keresése